Skip directly to content

Publications

Meet Britain's longest surviving heart transplant patient

MedWorm Heart Transplant - Mon, 06/12/2017 - 14:29
Paul Hayman, 49, from Plymouth, underwent the risky transplant at the Papworth Hospital, Cambridge, in 1987 and has had the same donor heart beating away inside his chest ever since. (Source: the Mail online | Health)
Categories: Publications

New Risk Model May Help Select Patients With HCC for Liver Transplantation New Risk Model May Help Select Patients With HCC for Liver Transplantation

MedWorm Liver Transplant - Fri, 06/09/2017 - 19:10
A new risk score to predict five-year survival after liver transplant of patients with hepatocellular carcinoma (HCC) displayed better prognostic ability than other models when tested in a database of nearly 14,000 patients.Reuters Health Information (Source: Medscape Medical News Headlines)
Categories: Publications

MassDevice.com +5 | The top 5 medtech stories for June 8, 2017

MedWorm Liver Transplant - Thu, 06/08/2017 - 18:00
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Sanuwave Health inks dev deal with eKare for wound care integration Sanuwave Health said today it entered a memorandum of understanding with eKare to develop novel wound care analysis and management solutions which integrates technology from both companies. Through the deal, Sanuwave’s dermaPace wound treatment device will be linked with eKare’s inSight 3D wound imaging and analytics system...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

Surefire Medical touts infusion tech in liver cancer trial

MedWorm Liver Transplant - Thu, 06/08/2017 - 13:04
Surefire Medical touted data today from a retrospective analysis of 85 bridge-to-transplant liver cancer patients treated with transarterial chemoembolization. The data showed that therapy delivered using the Surefire infusion system yielded an 80% complete response in 1 treatment compared to 52% with a standard endhole microcatheter. The analysis also demonstrated a lower recurrence rate of liver cancer at 1 month for patients that used Surefire’s technology instead of a conventional microcatheter. Get the full story at our sister site, Drug Delivery Business News. The post Surefire Medical touts infusion tech in liver cancer trial appeared first on MassDevice. (Source: Mass Device)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

Prevention of HCV Recurrence Following Liver Transplant Prevention of HCV Recurrence Following Liver Transplant

MedWorm Liver Transplant - Thu, 06/08/2017 - 04:15
This study evaluated whether a bridging SOF-regimen from pre- to post-liver transplant is safe and effective in preventing HCV re-infection.Liver International (Source: Medscape Today Headlines)
Categories: Publications

Artificial Heart Valve Approved for Valve-in-Valve Treatment (FREE)

MedWorm Heart Transplant - Tue, 06/06/2017 - 23:00
By Kristin J. Kelley Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Sapien 3 transcatheter heart valves may now be used as " a valve-in-valve " … (Source: Physician's First Watch current issue)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

Using Viruses to Boost Mesothelioma Immunotherapy

MedWorm Lung Transplant - Tue, 06/06/2017 - 16:02
Immunotherapy through clinical trials is becoming a promising treatment option for some mesothelioma patients. Checkpoint inhibitor drugs, such as Keytruda, already have U.S. Food and Drug Administration (FDA) approval as first-line treatments for non-small cell lung cancer (NSCLC), edging immunotherapy drugs closer to becoming a viable second-line therapy for other thoracic cancers, including pleural mesothelioma. However, overall response to immune therapies remains relatively low. Researchers across the country are striving to enhance responsiveness to immunotherapy drugs. Leading that trend is viroimmunotherapy, or the process of combining cancer-killing (oncolytic) viruses with immunotherapy drugs. Dr. Manish Patel, an assistant professor in the division of hematology, oncology and...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

#FDA expands use of Sapien 3 artificial heart valve 4 high-risk patients https://go.usa.gov/xNEGz   #heartdisease #medicaldevice

MedWorm Heart Transplant - Tue, 06/06/2017 - 11:13
#FDA expands use of Sapien 3 artificial heart valve 4 high-risk patients https://go.usa.gov/xNEGz  #heartdisease #medicaldevice (Source: Food and Drug Adminstration (FDA): CDRHNew)
Categories: Publications

FDA approves new use for Edwards' Sapien 3 heart valve

MedWorm Heart Transplant - Mon, 06/05/2017 - 19:41
(Reuters) - The U.S. Food and Drug Administration on Monday approved Edwards Lifesciences Corp's Sapien 3 artificial heart valve for high-risk patients whose previously implanted heart valves are failing, a procedure designed to avoid repeat open heart surgery. (Source: Reuters: Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

FDA expands use of Sapien 3 artificial heart valve for high-risk patients

MedWorm Heart Transplant - Mon, 06/05/2017 - 18:44
The U.S. Food and Drug Administration today approved an expanded indication for the Sapien 3 Transcatheter Heart Valve (THV) for patients with symptomatic heart disease due to failure of a previously placed bioprosthetic aortic or mitral valve whose risk of death or severe complications from repeat surgery is high or greater. (Source: Food and Drug Administration)
Categories: Publications

The Perioperative Lung Transplant Virome The Perioperative Lung Transplant Virome

MedWorm Lung Transplant - Mon, 06/05/2017 - 04:14
Explore the role torque teno viruses may play in primary graft dysfunction after lung transplantation.American Journal of Transplantation (Source: Medscape Today Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

Man who was denied life-saving lung transplant over marijuana use dies

MedWorm Lung Transplant - Sun, 06/04/2017 - 08:45
(Natural News) Riley Hancey, the Park City, Utah man initially denied of a lung transplant at the University of Utah over marijuana use, passed away at the Hospital of the University of Pennsylvania. The cause of death was due in part to complications of double lung transplant he received from the latter. Riley was surrounded by... (Source: NaturalNews.com)
Categories: Publications

Professor who campaigned to ban trans fats dies at 102

MedWorm Heart Transplant - Fri, 06/02/2017 - 13:21
Fred Kummerow sounded equal parts relieved and content on that Tuesday afternoon in June 2015. The Food and Drug Administration had decided to ban artificial trans fats from the U.S. food supply, finally eliminating a key culprit in the rising rates of heart disease in the nation. Kummerow, then a 100-year-old University of Illinois professor, had […]Related:‘Drug tourists’ keep overdosing at this library. Here’s how employees are saving their lives.Health officials vow to develop drugs to curb the opioid epidemicMore than a third of teenage girls experience depression, new study says (Source: Washington Post: To Your Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

3 require liver transplants after eating "death cap" mushrooms

MedWorm Liver Transplant - Fri, 06/02/2017 - 13:14
Toddler who ate the wild mushrooms suffered permanent brain damage (Source: Health News: CBSNews.com)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

Twist of fate: Anna reconnects with the oncologist who saved her life

MedWorm Heart Transplant - Fri, 06/02/2017 - 11:00
Credit: Mark Dela Cruz Anna Protsiou was five in 2002 when she was diagnosed with neuroblastoma. She remembers pain and the fruit-scented anesthesia masks that led her to stop eating cherries. She remembers hospital arts and crafts projects. What she barely remember is the pediatric oncologist who saved her life. She was a young girl then who didn’t speak English, moving with her family from their native Greece to be treated for a year at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Now, after moving with her family to Canada in 2014, she’s a 20-year-old dance student at the Eg. School of Contemporary Dancers/ University of Winnipeg and a contortionist with a rubber-band body. She’s ready to claim her history as her own, ready to move beyond photographs of the d...
Categories: Publications

Wild 'Death Cap' Mushroom Sickens 14 in California

MedWorm Liver Transplant - Thu, 06/01/2017 - 19:15
Foraging by novices tied to 3 people needing liver transplants and permanent brain damage in a child (Source: WebMD Health)
Categories: Publications

Wild'Death Cap' Mushroom Seriously Sickens 14 in California

MedWorm Liver Transplant - Thu, 06/01/2017 - 17:00
Foraging by novices tied to 3 people needing liver transplants and permanent brain damage in a child Source: HealthDay Related MedlinePlus Pages: Poisoning (Source: MedlinePlus Health News)
Categories: Publications

Could You, Would You Save A Life? This CPR-AED Awareness Week, Vow To Know How

MedWorm Heart Transplant - Tue, 05/30/2017 - 12:27
As she prepared for the PurpleStride 5K in Kansas City a few weeks ago, Brooke Worrel took her time attaching the racing number to her shirt. This usually mindless task was a lot tougher with all the tears filling her eyes. One year before, she ran this race with her dad. She finished. He didn’t. Shortly after crossing the finish line, 16-year-old Brooke went back on the course to join Rick at the end of his run. When she reached him, Rick was on the ground, blood pouring from the left side of his face and his right knee. Men on both sides of him were performing CPR. *** Rick Worrel’s grandfather died at age 55. So did his dad. Rick was 55 when he and Brooke ran that 5K on May 14, 2016. But Rick’s heart story dates to the day before Thanksgiving in 2014. To a routine trip to the gym...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

New drug reduces transplant and mortality rates significantly in patients with hepatitis C

MedWorm Liver Transplant - Fri, 05/26/2017 - 03:00
(Intermountain Medical Center) Patients with hepatitis C who suffer from advanced stages of liver disease have renewed hope, thanks to findings by researchers who have discovered that a new drug significantly reduces their risk of death and need for transplantation. (Source: EurekAlert! - Infectious and Emerging Diseases)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

Mauna Kea touts data from Cellvizio lung transplant study

MedWorm Lung Transplant - Thu, 05/25/2017 - 21:02
This study provides further evidence of the broad potential of the Cellvizio platform to improve diagnostic and treatment outcomes. We thank Dr. Keller and his colleagues for conducting this unique study sponsored by Mauna Kea Technologies and demonstrating that with proper training, the procedure is effective and reproducible. We are optimistic that Cellvizio will increasingly be used in a variety of applications that can benefit from its unique ability to provide real-time diagnostic information at the cellular level. Moreover, image interpretation automation with artificial intelligence will contribute to the performance and adoption of Cellvizio in this and other applications,” CEO & founder Sacha Loiseau said in a press release. Earlier this month, Mauna Kea said it won 510...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

Pages